<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 20 Jul 2022 16:15:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial</title>
   <link>http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Wellbeing+Subsidiary+KGK+Science+Enters+Into+Research+Contract+With+Halucenex+for+Phase+II+Clinical+Trial/20348080.html</guid>
   <pubDate>Wed, 20 Jul 2022 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KONEF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26315875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36953544</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SQ2</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Sierra Sage Herbs Acquired By Creso Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Sierra+Sage+Herbs+Acquired+By+Creso+Pharma/19565543.html</guid>
   <pubDate>Mon, 07 Feb 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1X8</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CPH</category>
   	  </item>
  <item>
   <title>Red Light Holland and Creso Pharma Agree to Terminate Merger</title>
   <link>http://www.streetinsider.com/Press+Releases/Red+Light+Holland+and+Creso+Pharma+Agree+to+Terminate+Merger/18880086.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Red+Light+Holland+and+Creso+Pharma+Agree+to+Terminate+Merger/18880086.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Red+Light+Holland+and+Creso+Pharma+Agree+to+Terminate+Merger/18880086.html</guid>
   <pubDate>Mon, 30 Aug 2021 08:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	  </item>
  <item>
   <title>Red Light Holland and Creso Pharma Agree to Terminate Merger</title>
   <link>http://www.streetinsider.com/Newsfile/Red+Light+Holland+and+Creso+Pharma+Agree+to+Terminate+Merger/18880086.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Newsfile/Red+Light+Holland+and+Creso+Pharma+Agree+to+Terminate+Merger/18880086.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/Red+Light+Holland+and+Creso+Pharma+Agree+to+Terminate+Merger/18880086.html</guid>
   <pubDate>Mon, 30 Aug 2021 08:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	  </item>
  <item>
   <title>Red Light Holland Provides Initial FAQ in connection with Transaction with Creso Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Red+Light+Holland+Provides+Initial+FAQ+in+connection+with+Transaction+with+Creso+Pharma/18581406.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Red+Light+Holland+Provides+Initial+FAQ+in+connection+with+Transaction+with+Creso+Pharma/18581406.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Red+Light+Holland+Provides+Initial+FAQ+in+connection+with+Transaction+with+Creso+Pharma/18581406.html</guid>
   <pubDate>Mon, 21 Jun 2021 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">COPHF</category>
   	  </item>
 </channel>
</rss>
